Cargando…
Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
We have recently demonstrated that, fibroblast growth factor 2 (FGFR2), signalling via ribosomal S6 kinase 2 (RSK2), promotes progression of breast cancer (BCa). Loss of progesterone receptor (PR), whose activity in BCa cells can be stimulated by growth factor receptors (GFRs), is associated with po...
Autores principales: | Piasecka, Dominika, Kitowska, Kamila, Czaplinska, Dominika, Mieczkowski, Kamil, Mieszkowska, Magdalena, Turczyk, Lukasz, Skladanowski, Andrzej C., Zaczek, Anna J., Biernat, Wojciech, Kordek, Radzislaw, Romanska, Hanna M., Sadej, Rafal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349893/ https://www.ncbi.nlm.nih.gov/pubmed/27852068 http://dx.doi.org/10.18632/oncotarget.13322 |
Ejemplares similares
-
FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
por: Turczyk, Lukasz, et al.
Publicado: (2017) -
Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016) -
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
por: Piasecka, Dominika, et al.
Publicado: (2019) -
FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022) -
Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli
por: Piasecka, Dominika, et al.
Publicado: (2020)